Zurich (Switzerland), - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced ...

UC San Diego researchers reveal PHGDH as a causal gene in Alzheimer's, linking its regulatory role to disease progression and ...